Introduction

Chandler's syndrome is an extremely uncommon eye condition. It belongs to a class of illnesses known as ICE syndromes.¹ The cells inside the transparent front portion of the eye behave abnormally in this condition. They begin to migrate to other areas of the eye, such as the iris (the coloured portion) and the drainage channels that aid in the removal of fluid from the eye rather than remaining where they are supposed to be and carrying out their function. Eye pressure may rise as a result of this aberrant movement, which can also cause the cornea to swell, the iris to thin, and scar-like patches that prevent the fluid from draining correctly.

The appearance of secondary glaucoma is one of the main issues with Chandler's syndrome. This occurs as a result of an obstruction in the eye fluid's normal drainage pathway, which raises intraocular pressure. Glaucoma can harm the optic nerve and result in irreversible vision loss if treatment is not received.

Although medications and eye drops can be helpful, they typically don't keep the pressure under control for very long in these patients. For this reason, surgery is frequently required. One of the conventional methods for treating glaucoma has long been trabeculectomy. It lowers intraocular pressure by establishing a new fluid drainage channel.

This article will examine the effectiveness of trabeculectomy for Chandler's syndrome, its success rates, potential complications that patients and physicians should be aware of, and alternative treatment options.

An Overview of Chandler's Syndrome

The ICE spectrum, which also includes Cogan-Reese syndrome and progressive iris atrophy, includes Chandler's syndrome.² The corneal endothelial cells, which typically aid in maintaining the cornea's clarity, begin acting strangely in all three cases. They spread into inappropriate areas and lose their ability to pump.

This leads to a number of typical symptoms in Chandler's syndrome:

The iris begins to thin in certain areas; the cornea takes on a gleaming, hammered-silver appearance; and adhesions, known as peripheral anterior synechiae cause the drainage angle to gradually close.

This process raises eye pressure over time.

The condition is more common in women and typically affects people in their middle years. Although the other eye may occasionally exhibit very slight symptoms, it usually only affects one eye. Patients frequently experience eye pain from corneal swelling, halos around lights, or blurred vision. However, the primary threat to vision is glaucoma, which affects over half of patients.³

A slit-lamp examination, gonioscopy, and specialised imaging techniques like specular microscopy are used by doctors to diagnose Chandler's syndrome.

Glaucoma in Chandler’s Syndrome

Between 50 and 70 percent of individuals with Chandler's syndrome develop glaucoma. Regretfully, it is typically hard to control. Eye drops may provide short-term relief, but the drainage angle keeps closing as new adhesions form.

The scarring and closure of the drainage structures is the issue here, not the pupil or trabecular meshwork itself, which is why laser treatments like iridotomy or trabeculoplasty, which are successful in treating other forms of glaucoma, do not work well.

Therefore, trabeculectomy is typically regarded as the first option, and surgery is frequently the only way to maintain pressure under control.

Trabeculectomy: What It Involves

A trabeculectomy is one of the most common glaucoma operations performed worldwide.⁴ Making a new passageway for fluid to leave the eye is the aim.

The surgeon makes a tiny incision in the sclera, the white part of the eye, and a tiny opening in the chamber of the eye. This allows the fluid to enter a small reservoir beneath the outer layer of the eye called a bleb, which looks like a blister. After that, the surrounding tissues absorb the fluid.

To reduce scarring, doctors often use special medications such as mitomycin-C or 5-fluorouracil during the procedure.⁵ The surgery's long-term success rate is raised by these drugs. For patients with more prevalent types of glaucoma, trabeculectomy usually results in a significant reduction in pressure that lasts for years. The results of Chandler's syndrome, however, are less obvious.

How Effective Is Trabeculectomy in Chandler's Syndrome?

Trabeculectomy is effective, but not always for a long time.

Trabeculectomy typically effectively reduces pressure in the short term. After surgery, many patients report that their pressure stays constant and that they require fewer drops. This control may persist for years for some people. Long-term outcomes, however, are less promising. Research indicates that trabeculectomy fails more frequently in ICE syndromes, such as Chandler's, than in common forms of glaucoma^6. Around the surgical site, the aberrant endothelial cells continue to proliferate and leave scars. Bleb failure results from this, in which the newly installed drainage pathway ceases to function.

According to one study, a significant portion of patients needed another operation within five years,⁷ even though many did well at first. Another difficulty is that, even with properly managed pressure, Chandler's syndrome itself can result in corneal abnormalities that impair vision. Nevertheless, many patients, particularly in the initial years following surgery, report some stabilisation of their vision and relief from symptoms such as eye pain following trabeculectomy.

Trabeculectomy Complications in Chandler's Syndrome

Trabeculectomy has risks, just like any other surgery. Complications are more frequent and can be more serious in Chandler's syndrome.

• The most common issue is bleb failure.⁸ The new drainage channel is blocked by scarring, which causes high pressure to return
• Hypotony, or low eye pressure, can harm the retina or result in a shallow front of the eye
• Because the bleb makes a weak spot in the outer wall of the eye, infections like blebitis or endophthalmitis can develop, sometimes years after surgery
• Of particular concern is corneal decompensation. Even when the pressure is managed, trabeculectomy can occasionally exacerbate swelling because Chandler's syndrome already weakens the cornea
• It is frequently necessary to have follow-up surgeries, such as a drainage implant, another trabeculectomy, or other operations

Compared to more common glaucoma cases like primary open-angle glaucoma, trabeculectomy is generally riskier in Chandler's syndrome.

Alternative Surgical Techniques

Alternative surgeries are frequently considered by doctors due to the difficulties associated with trabeculectomy.

• An alternative drainage pathway is offered by glaucoma drainage implants, such as Ahmed or Baerveldt tubes. It has been demonstrated that these implants, which avoid the obstructed drainage structures, offer more dependable long-term outcomes for glaucoma associated with ICE⁹
• Rather than generating new drainage, cyclodestructive techniques, such as transscleral cyclophotocoagulation, decrease the amount of fluid produced by the eye. They are frequently saved for challenging situations in which previous surgeries have failed
• Corneal transplantation (penetrating keratoplasty) may be used in conjunction with glaucoma surgery for patients who also experience severe corneal issues in order to restore both corneal clarity and pressure control

Many specialists think drainage implants might be a better long-term option for patients with Chandler's syndrome, even though trabeculectomy still has a place.¹⁰

Which Patients Benefit from Trabeculectomy the Most?

The patient's general eye health and the disease's stage determine the outcome of trabeculectomy.

• Patients who have surgery sooner, before significant corneal damage or scarring, have better results
• Advanced cases with extensive angle closure, notable iris atrophy, or corneal swelling are more likely to have worse results
• Because of scarring, patients who have previously undergone eye surgery are also more likely to have a failed trabeculectomy

For this reason, physicians stress customised treatment planning. Before selecting the best surgery, a thorough evaluation by glaucoma and corneal specialists is frequently required.

Prospects for the Future

There is continuous research to enhance the surgical results for Chandler's syndrome. To lessen scarring and increase the success rates of trabeculectomy, new antifibrotic medications are being developed.

Furthermore, minimally invasive glaucoma surgery, or MIGS, is becoming more and more well-liked. In extreme situations, such as ICE syndromes, these procedures might not sufficiently reduce pressure, despite the fact that they are typically safer and have faster recovery times.

Summary

Chandler's syndrome. Instead of only treating complications like glaucoma, it might be possible to address the underlying cause if future treatments can halt or reverse these changes. Chandler's syndrome is an uncommon condition that can cause severe, treatment-resistant glaucoma. Trabeculectomy is a long-standing surgical option that can temporarily reduce eye pressure. However, long-term success is often limited by corneal damage and persistent scarring.

Compared to typical glaucoma cases, infections, bleb failure, and worsening corneal oedema are more common complications. Many patients eventually need additional surgery, such as glaucoma drainage implants, which often provide better long-term control. Tracebulectomy is still used, especially in some patients with less advanced disease, despite the fact that its results vary. With individualised care, close monitoring, and collaboration between glaucoma and corneal specialists, Chandler's syndrome can be effectively managed. According to new surgical techniques and continuing research into endothelial cell biology, future treatments may offer more reliable ways to preserve these patients' vision.